(And why borrowing from SaaS keeps failing)
Healthcare GTM strategy is often built by importing playbooks that worked elsewhere: SaaS, fintech, and horizontal B2B sales models. The logic feels sound: “Buying is buying. We just need to adjust messaging.”
But healthcare is not a vertical flavor of B2B. It is a fundamentally different decision system. When teams reuse generic playbooks, failure isn’t dramatic. It is slow, expensive, and confusing. Pipelines fill. Revenue doesn’t.
Most GTM playbooks are built on assumptions that hold in flat markets: buyers self-identify, and authority sits close to usage.
Healthcare violates every one.
Healthcare buying is layered, regulated, risk-driven, committee-based, and externally influenced. Applying flat-market GTM logic to a layered ecosystem guarantees friction.
Let’s analyze why standard B2B motions fail to gain traction in the healthcare ecosystem.
When growth stalls, teams typically respond by adding SDRs and increasing outreach. In healthcare, this backfires. More activity without context increases noise, degrades credibility, and hits the wrong layers.
Healthcare doesn’t reward pressure. It rewards precision.
Traditional GTM frameworks assume you can identify "the buyer" and that they control the process. In healthcare, buyers are collective and authority is distributed.
Asking "Who is the buyer?" is the wrong question. The right question is: "Where does this decision resolve?" Until GTM strategy answers that, execution remains guesswork.
Generic GTM emphasizes positioning and differentiation. These matter, but they are downstream. In healthcare, the primary constraint is not understanding. It is readiness.
If the organization is not under pressure, the best message won’t convert. Healthcare GTM fails when it tries to persuade before conditions exist to buy.
Healthcare timing is often described as "slow." It isn't slow. It is gated. Decisions move when risk thresholds are crossed or regulatory deadlines approach.
Traditional GTM sees none of this. So teams push early, stall, and blame the market.
Healthcare GTM needs intelligence that answers which ecosystem layer controls the decision and where intent is emerging. Without this, ICPs are theoretical and targeting is noisy.
This is not a tooling gap. It is a model gap.
A successful healthcare GTM playbook starts upstream of execution. It requires a fundamental shift in how you model the market.
This is the logic Intent.Health is built on.
Healthcare doesn’t need better GTM tactics. It needs a different mental model. One that accepts complexity as structure, timing as signal, and precision as leverage.
When GTM aligns with how healthcare actually decides, growth stops feeling forced and starts feeling inevitable. That’s not a better playbook. It’s the right one.